BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 34910336)

  • 1. Comparison of IL-6 measurement methods with a special emphasis on COVID-19 patients according to equipment and sample type.
    Choi YJ; Roh J; Kim S; Lee KA; Park Y
    J Clin Lab Anal; 2022 Jan; 36(1):e24182. PubMed ID: 34910336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Automated Fluorescent Immunoassay System With Roche Elecsys and Beckman Coulter Access 2 Assays for Anti-Müllerian Hormone Measurement.
    Han A; Suh B; Yi G; Lee YJ; Kim SE
    Ann Lab Med; 2022 Jan; 42(1):47-53. PubMed ID: 34374348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect Hepatitis B Surface Antigen (HBsAg), Antibody to HBsAg, and Antibody to Hepatitis C.
    Ryu JH; Kwon M; Moon JD; Hwang MW; Lee JM; Park KH; Yun SJ; Bae HJ; Choi A; Lee H; Jung B; Jeong J; Han K; Kim Y; Oh EJ
    Ann Lab Med; 2018 Nov; 38(6):578-584. PubMed ID: 30027702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain.
    Poljak M; Oštrbenk Valenčak A; Štamol T; Seme K
    J Clin Virol; 2021 Apr; 137():104784. PubMed ID: 33711693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of rapid SARS-CoV-2 antigen tests, AFIAS COVID-19 Ag and ichroma COVID-19 Ag, with serial nasopharyngeal specimens from COVID-19 patients.
    Kweon OJ; Lim YK; Kim HR; Choi Y; Kim MC; Choi SH; Chung JW; Lee MK
    PLoS One; 2021; 16(4):e0249972. PubMed ID: 33831118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical and Clinical Evaluation of the Automated Elecsys Anti-SARS-CoV-2 Antibody Assay on the Roche cobas e602 Analyzer.
    Chan CW; Parker K; Tesic V; Baldwin A; Tang NY; van Wijk XMR; Yeo KJ
    Am J Clin Pathol; 2020 Oct; 154(5):620-626. PubMed ID: 32814955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott).
    Charpentier C; Ichou H; Damond F; Bouvet E; Chaix ML; Ferré V; Delaugerre C; Mahjoub N; Larrouy L; Le Hingrat Q; Visseaux B; Mackiewicz V; Descamps D; Fidouh-Houhou N
    J Clin Virol; 2020 Nov; 132():104618. PubMed ID: 32919222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay.
    Kittel M; Findeisen P; Muth MC; Thiaucourt M; Gerhards C; Neumaier M; Haselmann V
    Int J Infect Dis; 2021 Apr; 105():632-638. PubMed ID: 33578017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of a SARS-CoV-2 rapid antigen test among military and civilian personnel of an Air Force airport in central Italy.
    Verde P; Marcantonio C; Costantino A; Martina A; Simeoni M; Taffon S; Tritarelli E; Campanella C; Cresta R; Bruni R; Ciccaglione AR; Pisani G; Nisini R; Spada E
    PLoS One; 2022; 17(11):e0277904. PubMed ID: 36441672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations.
    Yang J; Pederson EC; Hamilton C; Neibauer T; Robyak K; McGhee P; Speicher T; Zhu Y
    J Appl Lab Med; 2021 Mar; 6(2):441-450. PubMed ID: 33152084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance Evaluation of the Automated Fluorescent Immunoassay System Rotavirus Assay in Clinical Samples.
    Kim JS; Lee SK; Ko DH; Hyun J; Kim HS
    Ann Lab Med; 2019 Jan; 39(1):50-57. PubMed ID: 30215230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre-pandemic controls.
    Jung K; Shin S; Nam M; Hong YJ; Roh EY; Park KU; Song EY
    J Clin Lab Anal; 2021 Sep; 35(9):e23921. PubMed ID: 34369009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of the Roche IL-6 chemiluminescent immunoassay in patients with COVID-like respiratory symptoms.
    Lau CS; Hoo SP; Koh JMJ; Phua SK; Aw TC
    J Virol Methods; 2021 Oct; 296():114224. PubMed ID: 34214571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico.
    Avila-Nava A; Cortes-Telles A; Torres-Erazo D; López-Romero S; Chim Aké R; Gutiérrez Solis AL
    Cytokine; 2021 Jul; 143():155543. PubMed ID: 33896708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Performance Assessment of Novel Fluorescence Immunoassay POCTs for Measuring Circulating Levels of Vitamin-D.
    Palermiti A; Manca A; Mastrantonio F; Maiese D; Curatolo A; Antonucci M; Simiele M; De Nicolò A; D'Avolio A
    Molecules; 2024 Apr; 29(7):. PubMed ID: 38611915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentre Performance Evaluation of the Elecsys Anti-SARS-CoV-2 Immunoassay as an Aid in Determining Previous Exposure to SARS-CoV-2.
    Riester E; Majchrzak M; Mühlbacher A; Tinguely C; Findeisen P; Hegel JK; Laimighofer M; Rank CM; Schönfeld K; Langen F; Laengin T; Niederhauser C
    Infect Dis Ther; 2021 Dec; 10(4):2381-2397. PubMed ID: 34368915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection.
    Chua KYL; Vogrin S; Bittar I; Horvath JH; Wimaleswaran H; Trubiano JA; Holmes NE; Lam Q
    Pathology; 2020 Dec; 52(7):778-782. PubMed ID: 33039094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results from a multicenter evaluation of the 4th generation Elecsys Troponin T assay.
    Hermsen D; Apple F; Garcia-Beltràn L; Jaffe A; Karon B; Lewandrowski E; Mühlbacher A; Müller R; Ordóñez J; Pagani F; Panteghini M; Plecko T; Jarausch J
    Clin Lab; 2007; 53(1-2):1-9. PubMed ID: 17323819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay.
    Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Tancevski I; Weiss G; Anliker M; Griesmacher A; Hoermann G
    Clin Chem Lab Med; 2021 May; 59(6):1143-1154. PubMed ID: 33554557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of six immunoassays for the detection of antibodies against SARS-CoV-2.
    Pérez-García F; Pérez-Tanoira R; Iglesias ME; Romanyk J; Arroyo T; Gómez-Herruz P; González R; Lapeña García S; Cuadros-González J
    J Virol Methods; 2021 Mar; 289():114047. PubMed ID: 33338544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.